Found 8 clinical trials
Treatment of Citalopram for Anxiety Disorders Following a Traumatic Brain Injury
after a 12-week course of citalopram than after a 12-week course of placebo.
- 154 views
- 07 Nov, 2020
- 1 location
Citalopram as a Posterior Cortical Protective Therapy in Parkinson Disease
This Parkinson disease (PD) trial will test whether 26 months of citalopram, compared to placebo, can alter the build-up of toxic amyloid-beta plaques in the visuospatial cortex of the brain
- 0 views
- 14 Jul, 2021
- 1 location
Safety of Liposom With Citalopram in Elderly Patients With Major Depressive Disorder
The purpose of this study is to determine if Liposom Forte will enhance the response to antidepressant therapy with citalopram in elderly patients suffering from Major Depressive Disorder (MDD
- 0 views
- 02 Aug, 2021
- 16 locations
Neurobiological Processing of Emotions in Depression
Depression is one of the most common invalidating mental disorders, ranked by World Health Organization as the single largest contributor to global disability. Its occurrence and development, besides stress and other neurobiological/genetic correlates, has been significantly associated with exposure to traumatic experiences (e.g., physical and sexual abuse, emotional neglect). Major …
- 12 views
- 25 Jan, 2021
- 2 locations
Cognitive vs. Emotional Psychopharmacological Manipulations of Fear vs. Anxiety
and anxiogenic effects of various compounds such as alprazolam, citalopram, hydrocortisone, and oxytocin in healthy participants. We propose in a first step (step-1) to start with a simple
- 35 views
- 20 Jul, 2021
- 1 location
Determining Optimal Treatment Sequences in Anxious Depression (DOTS-AD)
Acute, double-blind, adaptively randomized treatment with duloxetine or escitalopram, followed by double-blind, randomized adjunctive treatment with clonazepam or pregabalin for persistent symptoms.
- 350 views
- 25 Jan, 2021
- 1 location
7-day Simvastatin and Emotional Processing
Work in our group has revealed that short-term (7-day) administration of antidepressants produces positive biases in the processing of emotional information in healthy volunteers. Such effect might be an important neuropsychological mechanism of antidepressant action. The current study will investigate the effect of seven-day administration of simvastatin 20mg on emotional …
- 0 views
- 28 Jan, 2021
- 1 location
Clinical Trial Readiness for SCA1 and SCA3
The investigators plan to fill the gap between the current state of clinical trial readiness and the optimal one for SCA1 and SCA3, which are fatal rare diseases with no treatments. Through US-European collaborations, the investigators will establish the world's largest cohorts of subjects at the earliest disease stages, who …
- 267 views
- 14 Jul, 2021
- 1 location